I

I Sens Inc
KOSDAQ:099190

Watchlist Manager
I Sens Inc
KOSDAQ:099190
Watchlist
Price: 16 560 KRW 2.54% Market Closed
Market Cap: 459B KRW

Net Margin
I Sens Inc

0.4%
Current
3%
Average
1.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0.4%
=
Net Income
1.1B
/
Revenue
299B

Net Margin Across Competitors

I Sens Inc
Glance View

Market Cap
457.7B KRW
Industry
Health Care

i-SENS, Inc. engages in development and manufacture of medical, environmental, industrial sensors. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-01-30. The Company’s products consist of blood glucose monitoring systems, including blood glucose monitors, blood glucose meters, glucose monitors, blood glucose meter kits and blood sugar meters under the brand names of CareSens, MedTrust, BGStar, Barozen and others; electrolyte analyzers and cartridges; immunosensors, as well as other related accessories, such as connectors, lancets, blood glucose data management software and lancing devices, among others. The firm distributes its products within domestic market and to overseas markets including Japan, Europe, the United States and others.

Intrinsic Value
32 661.67 KRW
Undervaluation 49%
Intrinsic Value
Price
I
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0.4%
=
Net Income
1.1B
/
Revenue
299B
What is the Net Margin of I Sens Inc?

Based on I Sens Inc's most recent financial statements, the company has Net Margin of 0.4%.

Back to Top